1
Marianna Foldvari: Biphasic multilamellar lipid vesicles. PharmaDerm Laboratories, Judy M Dehlinger & Associates Mohr, December 29, 1998: US05853755 (62 worldwide citation)

A biphasic multilamellar lipid vesicle comprising a plurality of spaced apart lipid bilayers that include a liposome-forming component and optionally a biologically active agent entrapped within the lipid bilayers. The lipid vesicle also comprises peripheral aqueous solution compartments formed betw ...


2
Marianna Foldvari, Sam Kwadwo Attah Poku: Composition and method for dermal and transdermal administration of a cytokine. PharmaDerm Laboratories, Judy M Iota Pi Law Group Mohr, December 26, 2000: US06165458 (24 worldwide citation)

A composition for transdermal administration of a cytokine is described. The composition includes a conjugate composed of a cytokine, such as an interferon, and at least one fatty acid moiety covalently attached to the cytokine. The conjugate has enhanced cutaneous delivery relative to the cytokine ...


3
Marianna Foldvari: Method for preparing biphasic multilamellar lipid vesicles. PharmaDerm Laboratories, Judy M Dehlinger & Associates Mohr, November 30, 1999: US05993851 (15 worldwide citation)

A biphasic multilamellar lipid vesicle comprising a plurality of spaced apart lipid bilayers that include a liposome-forming component and optionally a biologically active agent entrapped within the lipid bilayers. The lipid vesicle also comprises peripheral aqueous solution compartments formed betw ...


4
Marianna Foldvari: Topical patch for liposomal drug delivery system. PharmaDerm Laboratories, Judy M Mohr, Peter J Dehlinger, February 17, 1998: US05718914 (14 worldwide citation)

A device for the dermal and transdermal delivery of liposomes or a formulation thereof. The device comprises an applicator element carrying a containment means to store the liposomes, a liposome delivery surface for the containment means to transfer the liposomes from storage to the skin when the su ...


5
Marianna Foldvari, Sam Attah Poku: Composition for transdermal and dermal administration of interferon-&agr;. PharmaDerm Laboratories, Judy M Mohr, Perkins Coie, December 2, 2003: US06656499 (7 worldwide citation)

A composition for transdermal and dermal administration of interferon-&agr; is described. The composition is comprised of lipid vesicles including a fatty acylated amino acid and an oil-in-water emulsion. Interferon-&agr; is entrapped in the vesicles.


6
Marianna Foldvari, Maria Baca Estrada: Biphasic lipid vesicle composition for transdermal administration of an immunogen. PharmaDerm Laboratories, Judy M Dehlinger & Associates Mohr, November 30, 1999: US05993852 (6 worldwide citation)

A composition for transdermal administration of an immunogen is described. The immunogen is entrapped in lipid vesicles having a oil-in-water emulsion in the central core compartment. The vesicles are administered transdermally to elicit an immune response in a subject.


7
Marianna Foldvari, Sam Kwadwo Attah Poku: Composition and method for dermal and transdermal administration of a cytokine. PharmaDerm Laboratories, Judy M Mohr, Jacqueline F Mahoney, Perkins Coie, September 3, 2002: US06444200 (1 worldwide citation)

A composition for transdermal administration of a cytokine is described. The composition includes a conjugate composed of a cytokine, such as an interferon, and at least one fatty acid moiety covalently attached to the cytokine. The conjugate has enhanced cutaneous delivery relative to the cytokine ...


8
Ildiko Badea, Ronald Verrall, Peng Yang, Marianna Foldvari, Jackson Chitanda, Deborah Michel: Drug delivery agents comprising cyclodextrin covalently linked to a gemini surfactant, and pharmaceutical compositions comprising the same. University of Saskatchewan, Schwegman Lundberg & Woessner P A, October 27, 2015: US09168306

This disclosure relates to cyclodextrin-based drug delivery agents that comprise a cyclodextrin moiety covalently linked to a moiety of a gemini surfactant. Pharmaceutical compositions comprising the drug delivery agent and a therapeutic agent are also disclosed.


9
Marianna Foldvari, Sam Kwadwo Attah Poku: Composition and method for dermal and transdermal administration of a cytokine. PharmaDerm Laboratories, Iota Pi Law Group, September 6, 2001: US20010019712-A1

A composition for transdermal administration of a cytokine is described. The composition includes a conjugate composed of a cytokine, such as an interferon, and at least one fatty acid moiety covalently attached to the cytokine. The conjugate has enhanced cutaneous delivery relative to the cytokine ...


10
Marianna Foldvari, Maria Baca Estrada: Biphasic lipid vesicle composition for transdermal administration of an immunogen. Pharmaderm Laboratories, lin xiaogong, December 20, 2000: CN98810498

The invention describes a composition for transdermal administration of an immunogen. The immunogen is entrapped in lipid vesicles having an oil-in-water emulsion in the central core compartment. The vesicles are administered transdermally to elicit an immune response in a subject.